Your session is about to expire
← Back to Search
Cognitive Behavioral Therapy for Smoking Cessation in HIV/AIDS
Study Summary
This trial is testing a cognitive-behavioral-based intervention to help smokers living with HIV quit smoking by reducing anxiety and depression.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I do not have untreated or unstable mental health issues.You smoke cigarettes every day.You use tobacco products regularly, except for cigarettes.I am between 18 and 79 years old.You are willing to stop smoking.I am willing and able to sign a consent form.I am between 18 and 79 years old.You are willing to stop smoking.You smoke cigarettes every day.You are currently receiving treatment to quit smoking.You are HIV-positive.I am willing and able to sign a consent form.I have undergone cognitive behavioral therapy for anxiety in the last year.
- Group 1: Time and Intensity-Match Control
- Group 2: QUIT Treatment for Smoking Cessation and Distress Tolerance
- Group 3: Standard of Care
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Would I qualify to contribute to this clinical research?
"The parameters to be admitted into this trial include being aged between 18 and 79, plus a history of smoking cigarettes. In total, 360 people will be enrolled in the study."
What is the current patient count for this experimental treatment?
"Affirmative. The trial's current status is recruiting according to clinicaltrials.gov, with the initial posting on December 19th 2019 and most recent editing occurring February 1st 2021. At 3 different sites, 360 individuals are sought for enrollment in this research project."
Does the clinical trial permit geriatric individuals to participate?
"According to the trial's eligibility criteria, patients must be between 18 and 79 years old in order to participate. For those outside of this age range, there are 436 trials for young participants and 1893 studies available for elderly individuals."
Is the research team currently recruiting participants for this experiment?
"According to the clinicaltrials.gov records, this medical study is actively seeking participants. The initial posting date was December 19th 2019 and it has since been modified on February 1st 2021."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
How responsive is this trial?
Typically responds via
Most responsive sites:
- Massachusetts General Hospital: < 24 hours
Average response time
- < 1 Day
Share this study with friends
Copy Link
Messenger